Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of oral midazolam versus dexmedetomidine for dental sedation premedication
IRCT20240806062670N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of midazolam and dexmedetomidine in Emergence agitation (EA) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Emergence agitation in recovery. Started Jan 2025; status: completed.
02
Drugs
midazolamdexmedetomidine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on IRCT20240806062670N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240806062670N1.